…
Zürich (www.aktiencheck.de) - Rating-Update:
Die Analysten der UBS stufen die Aktie von Intra-Cellular Therapies Inc. (ISIN: US46116X1019, WKN: A1XDTL, Ticker-Symbol: 23I,…
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Mizuho Securities USA bewerten die Aktie von Intra-Cellular Therapies Inc. (ISIN: US46116X1019, WKN:…
Kulmbach (www.aktiencheck.de) - Intra-Cellular Therapies-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…
Alzheimer’s disease treatment stocks are focused on Alzheimer’s disease, a degenerative brain disorder that results in declining memory and thinking…
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
…
NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
…
…
Intra-Cellular Therapies has earned an ‘Outperform’ rating in its initial coverage from Baird analysts who believe the biotechnology company’s strong…
NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
Does Intra-Cellular Therapies (ITCI) have what it takes to be a top stock pick for momentum investors? Lets find out.…
…
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
…
NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the…
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
Intra-Cellular (ITCI) delivered earnings and revenue surprises of 27.42% and 3.97%, respectively, for the quarter ended June 2023. Do the…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Q2 2023 total revenues increased to $110.8 million, compared to $55.6 million in the same period in 2022...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Durgam, Suresh K. - Vorstand - Tag der Transaktion: 2023-07-17...…
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
Intra-Cellular (ITCI) delivered earnings and revenue surprises of 26.98% and 3.44%, respectively, for the quarter ended March 2023. Do the…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Q1 2023 total revenues of $95.3 million, compared to $35.0 million in the same period in 2022...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the…
Van Nostrand Robert L. - Aufsichtsrat - Tag der Transaktion: 2023-04-17...…
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on…
Neumann, Mark - Vorstand - Tag der Transaktion: 2023-03-28...…
Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating lumateperone for the treatment of depression. Stock…
Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend…
read more...…
The companys depression drug, Caplyta (lumateperone), did well in a phase 3 trial against two types of depression....…
LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesdays pre-market trading (as of 08.15…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Shares of Intra-Cellular Therapies Inc. ITCI jumped about 15% in premarket trading on Tuesday after the company said its experimental…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Neumann, Mark - Vorstand - Tag der Transaktion: 2023-03-10...…
Durgam, Suresh K. - Vorstand - Tag der Transaktion: 2023-03-13...…
Halstead, Michael - Vorstand - Tag der Transaktion: 2023-03-13...…
Neumann, Mark - Vorstand - Tag der Transaktion: 2023-03-13...…
Halstead, Michael - Vorstand - Tag der Transaktion: 2023-03-10...…
Mates, Sharon - Vorstand - Tag der Transaktion: 2023-03-10...…
Hineline, Lawrence J. - Vorstand - Tag der Transaktion: 2023-03-10...…